Literature DB >> 6619047

Temocillin in peripheral lymph.

T Bergan, A Engeset, W Olszewski.   

Abstract

One gram of temocillin was given intravenously to five healthy volunteers to study the concentrations in serum and peripheral lymph obtained by cannulation of the lower leg. The 1 h serum level was 58.1 mg/l and the lymph level 14.3 mg/l. The mean peak lymph concentration was 30.6 mg/l and occurred between 1.5 and 2 h; the simultaneous serum level was 47.8 mg/l. The antibiotic levels in lymph were always below those in serum. The urinary recovery over 12 h was nearly 60%. The mean ratio between the areas under the concentration curves of lymph and serum was 0.558. The serum half-life was 4.9 h, the apparent beta-phase distribution volume 18.41. In comparison, the lymph half-life was 4.4 h. Protein binding appears to be of little consequence to the ability of temocillin to penetrate well into extravascular foci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619047     DOI: 10.1093/jac/12.1.59

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Treatment of severe infections with temocillin. Clinical and bacteriological evaluation.

Authors:  B Schulze; H D Heilmann
Journal:  Drugs       Date:  1985       Impact factor: 9.546

2.  Temocillin. In vitro antibacterial activity.

Authors:  B Slocombe; C E Cooper; K E Griffin; A R White
Journal:  Drugs       Date:  1985       Impact factor: 9.546

3.  Temocillin concentrations in human tissues.

Authors:  J G Gould; G Meikle; D L Cooper; R Horton
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Temocillin penetration of peripheral lymph.

Authors:  T Bergan; W L Olszewski; A Engeset
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion.

Authors:  Perrin Ngougni Pokem; Xavier Wittebole; Christine Collienne; Hector Rodriguez-Villalobos; Paul M Tulkens; Laure Elens; Françoise Van Bambeke; Pierre-François Laterre
Journal:  Antibiotics (Basel)       Date:  2022-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.